News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
407,508 Results
Type
Article (33307)
Company Profile (66)
Press Release (374135)
Multimedia
Podcasts (57)
Webinars (6)
Section
Business (115072)
Career Advice (1378)
Deals (24271)
Drug Delivery (97)
Drug Development (60263)
Employer Resources (110)
FDA (10151)
Job Trends (9244)
News (214647)
Policy (25734)
Tag
Academia (1864)
Accelerated approval (10)
Adcomms (24)
Allergies (80)
Alliances (42529)
ALS (77)
Alzheimer's disease (1190)
Antibody-drug conjugate (ADC) (129)
Approvals (10126)
Artificial intelligence (207)
Autoimmune disease (22)
Automation (10)
Bankruptcy (239)
Best Places to Work (7763)
BIOSECURE Act (16)
Biosimilars (99)
Biotechnology (45)
Bladder cancer (68)
Brain cancer (35)
Breast cancer (267)
Cancer (2237)
Cardiovascular disease (170)
Career advice (1156)
Career pathing (21)
CAR-T (140)
CDC (40)
Cell therapy (369)
Cervical cancer (17)
Clinical research (49349)
Collaboration (878)
Company closure (2)
Compensation (598)
Complete response letters (26)
COVID-19 (2536)
CRISPR (46)
C-suite (201)
Cystic fibrosis (66)
Data (2252)
Decentralized trials (1)
Denatured (9)
Depression (54)
Diabetes (292)
Diagnostics (3622)
Digital health (14)
Diversity (5)
Diversity, equity & inclusion (35)
Drug discovery (110)
Drug pricing (123)
Drug shortages (31)
Duchenne muscular dystrophy (129)
Earnings (41433)
Editorial (44)
Employer branding (18)
Employer resources (100)
Events (47248)
Executive appointments (418)
FDA (11401)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (6)
Funding (622)
Gene editing (97)
Generative AI (17)
Gene therapy (311)
GLP-1 (784)
Government (4241)
Grass and pollen (5)
Guidances (151)
Healthcare (11525)
HIV (38)
Huntington's disease (25)
IgA nephropathy (39)
Immunology and inflammation (119)
Immuno-oncology (10)
Indications (35)
Infectious disease (2716)
Inflammatory bowel disease (88)
Inflation Reduction Act (9)
Influenza (69)
Intellectual property (88)
Interviews (243)
IPO (10563)
IRA (44)
Job creations (1824)
Job search strategy (992)
Kidney cancer (8)
Labor market (30)
Layoffs (335)
Leadership (12)
Legal (7108)
Liver cancer (57)
Longevity (11)
Lung cancer (319)
Lymphoma (164)
Machine learning (10)
Management (32)
Manufacturing (324)
MASH (80)
Medical device (5990)
Medtech (5991)
Mergers & acquisitions (14286)
Metabolic disorders (762)
Multiple sclerosis (69)
NASH (20)
Neurodegenerative disease (105)
Neuropsychiatric disorders (32)
Neuroscience (1716)
NextGen: Class of 2025 (3742)
Non-profit (2799)
Now hiring (10)
Obesity (405)
Opinion (219)
Ovarian cancer (69)
Pain (67)
Pancreatic cancer (107)
Parkinson's disease (143)
Partnered (14)
Patents (216)
Patient recruitment (107)
Peanut (41)
People (26670)
Pharmaceutical (18)
Pharmacy benefit managers (14)
Phase I (14924)
Phase II (21439)
Phase III (17396)
Pipeline (1331)
Policy (204)
Postmarket research (1863)
Preclinical (6209)
Press Release (28)
Prostate cancer (121)
Psychedelics (33)
Radiopharmaceuticals (221)
Rare diseases (342)
Real estate (2635)
Recruiting (46)
Regulatory (16665)
Reports (23)
Research institute (1614)
Resumes & cover letters (210)
Rett syndrome (9)
RNA editing (5)
RSV (58)
Schizophrenia (80)
Series A (95)
Series B (65)
Service/supplier (4)
Sickle cell disease (39)
Special edition (9)
Spinal muscular atrophy (143)
Sponsored (21)
Startups (2006)
State (1)
Stomach cancer (12)
Supply chain (63)
Tariffs (59)
The Weekly (47)
Vaccines (828)
Venture capital (44)
Weight loss (277)
Women's health (21)
Worklife (10)
Date
Today (81)
Last 7 days (314)
Last 30 days (1183)
Last 365 days (20310)
2025 (11732)
2024 (22586)
2023 (25478)
2022 (33712)
2021 (36283)
2020 (34396)
2019 (28268)
2018 (21535)
2017 (20523)
2016 (18928)
2015 (21726)
2014 (16137)
2013 (12995)
2012 (13786)
2011 (14549)
2010 (13211)
Location
Africa (590)
Alabama (36)
Alaska (3)
Arizona (97)
Arkansas (5)
Asia (26578)
Australia (4758)
California (4666)
Canada (1505)
China (503)
Colorado (190)
Connecticut (204)
Delaware (147)
Europe (63936)
Florida (718)
Georgia (157)
Hawaii (3)
Idaho (30)
Illinois (373)
India (25)
Indiana (239)
Iowa (14)
Japan (180)
Kansas (68)
Kentucky (18)
Louisiana (12)
Maine (29)
Maryland (752)
Massachusetts (3380)
Michigan (127)
Minnesota (175)
Mississippi (1)
Missouri (57)
Montana (20)
Nebraska (10)
Nevada (52)
New Hampshire (26)
New Jersey (1455)
New Mexico (16)
New York (1385)
North Carolina (614)
North Dakota (5)
Northern California (2143)
Ohio (140)
Oklahoma (6)
Oregon (10)
Pennsylvania (992)
Puerto Rico (8)
Rhode Island (16)
South America (815)
South Carolina (18)
South Dakota (1)
Southern California (1734)
Tennessee (63)
Texas (581)
United States (17034)
Utah (105)
Virginia (133)
Washington D.C. (43)
Washington State (367)
West Virginia (2)
Wisconsin (37)
407,508 Results for "novartis ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Startups
Six Startups Changing The Way We Age
Armed with the latest biological knowledge and cutting-edge computational techniques—and, of course, investor dollars—these six biotechs are playing in the largely underappreciated longevity space, developing therapies that may improve the quality of aging.
July 9, 2025
·
11 min read
·
Tristan Manalac
I&I
Novartis Drops up to $1B+ for Drug Discovery Deal With Matchpoint
The partnership with Matchpoint Therapeutics gets Novartis global rights on all molecules for several unannounced inflammatory diseases identified through the biotech’s discovery platform.
July 24, 2025
·
2 min read
·
Dan Samorodnitsky
Deals
Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders
MorphoSys AG announces that Novartis BidCo Germany AG informed the MorphoSys AG Management Board of its intention to merge MorphoSys AG as transferring company into Novartis BidCo Germany AG.
June 20, 2024
·
4 min read
Startups
Longevity Biotechs Strive for Better Aging—Not Just Life Extension
The industry sector focused on aging is only about 10 years old, but acting on what scientists already know, a new crop of biotechs, backed by investors, are taking a disease-centric approach to extending the human lifespan.
July 9, 2025
·
3 min read
·
Tristan Manalac
Tariffs
Novartis ‘Moving as Fast as Possible’ to Fully Manufacture Key Drugs in US as Tariffs Near
In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO Vas Narasimhan told reporters that for most medicines, it typically takes three to four years to completely relocate production.
July 17, 2025
·
2 min read
·
Tristan Manalac
Immunology and inflammation
Late-Stage Stumble for Cosentyx Sets Novartis Back in Autoimmune Condition
Novartis is falling farther behind AbbVie, which expanded its JAK inhibitor Rinvoq into giant cell arteritis in April.
July 3, 2025
·
2 min read
·
Tristan Manalac
Artificial intelligence
Roche’s Chugai Breaks Into Aging via Potential $1B+ Deal With AI Outfit Gero
The partnership will give Chugai access to Gero’s artificial intelligence technology to discover novel targets in aging-related diseases. Chugai will then develop antibody-based drugs based on the findings.
July 7, 2025
·
2 min read
·
Dan Samorodnitsky
Collaboration
Alphabet Subsidiary Calico Colors In Up To $570M+ Aging Deal With China’s Mabwell
Calico will leverage 9MW3811’s anti-inflammatory mechanism to advance its mission of addressing aging-related diseases.
June 27, 2025
·
2 min read
·
Tristan Manalac
Spinal muscular atrophy
Novartis’ Intrathecal Zolgensma Effective in Older Children
After bringing Zolgensma to market in 2019 as the first gene therapy for spinal muscular atrophy, Novartis is back with an intrathecal formulation intended for older patients.
March 19, 2025
·
6 min read
·
Heather McKenzie
Rare diseases
Novartis’ Fabhalta Approved as First Therapy for Rare Kidney Disease
This is the third indication for Fabhalta after Novartis won FDA approval of the small molecule in paroxysmal nocturnal hemoglobinuria and primary immunoglobulin A nephropathy.
March 21, 2025
·
2 min read
·
Dan Samorodnitsky
1 of 40,751
Next
